{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T23:25:24Z","timestamp":1791761124074,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R310-2018-3711"],"award-info":[{"award-number":["R310-2018-3711"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adenosine is a purinergic signaling molecule with a wide range of physiological functions including anti- and pronociceptive properties. Adenosine receptors are expressed in the trigeminovascular system, and adenosine receptor antagonist, caffeine, relieves migraine headache. We performed a systematic review of the literature of preclinical data addressing the role of adenosine in migraine pathophysiology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      PubMed and EMBASE were searched for pre-clinical studies on the role of adenosine in migraine pathophysiology on September 5\n                      <jats:sup>th<\/jats:sup>\n                      , 2021.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 2510 studies were screened by title and abstract. Of these, thirteen pre-clinical studies evaluating\u00a0adenosine, adenosine A1, A2A and A3 receptors\u00a0were included.<\/jats:p>\n                    <jats:p>\n                      These studies showed that adenosine signaling pathway is involved in controlling vascular tone. Furthermore, electrical stimulation of the trigeminal ganglion modulates the expression of adenosine A\n                      <jats:sub>1<\/jats:sub>\n                      and A\n                      <jats:sub>2A<\/jats:sub>\n                      receptors in the trigeminal ganglion and trigeminal nucleus caudalis implicating adenosine signaling pathway in pain transmission.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Preclinical studies showed that adenosine has a dual effect on vasodilation and trigeminal pain pathway due to different receptor activation, suggesting a possible role of adenosine in migraine pathophysiology. Studies investigating pharmacological characteristics of subtypes of adenosine receptors are needed to further elucidate their role as a potential target for migraine treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-022-01412-0","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:09:36Z","timestamp":1649142576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies"],"prefix":"10.1186","volume":"23","author":[{"given":"Janu","family":"Thuraiaiyah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Kokoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Al-Mahdi","family":"Al-Karagholi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Messoud","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"1412_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2005.00967.x","author":"U Arulmani","year":"2005","unstructured":"Arulmani U, Heiligers JPC, Centuri\u00f3n D et al (2005) Lack of effect of the adenosine A1 receptor agonist, GR79236, on capsaicin-induced CGRP release in anaesthetized pigs. Cephalalgia. https:\/\/doi.org\/10.1111\/j.1468-2982.2005.00967.x","journal-title":"Cephalalgia"},{"key":"1412_CR2","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M (2020) Migraine. N Engl J Med 383:1866\u20131876. https:\/\/doi.org\/10.1056\/NEJMra1915327","journal-title":"N Engl J Med"},{"key":"1412_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1023\/A:1007850527878","volume":"14","author":"GF Baxter","year":"2000","unstructured":"Baxter GF, Hale SL, Miki T et al (2000) Adenosine A1 agonist at reperfusion trial (AART): Results of a three-center, blinded, randomized, controlled experimental infarct study. Cardiovasc Drugs Ther 14:607\u2013614. https:\/\/doi.org\/10.1023\/A:1007850527878","journal-title":"Cardiovasc Drugs Ther"},{"key":"1412_CR4","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1152\/physrev.00049.2017.-Adenosine","volume":"98","author":"PA Borea","year":"2018","unstructured":"Borea PA, Gessi S, Merighi S et al (2018) Pharmacology of Adenosine Receptors: The State of the Art. Physiol Rev 98:1591\u20131625. https:\/\/doi.org\/10.1152\/physrev.00049.2017.-Adenosine","journal-title":"Physiol Rev"},{"key":"1412_CR5","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/sleep\/20.12.1093","volume":"20","author":"DW Carley","year":"1997","unstructured":"Carley DW, Hagan RM, Sheehan M et al (1997) Adenosine A1 receptor agonist GR79236 suppresses apnea during all sleep stages in the rat. Sleep 20:1093\u20131098. https:\/\/doi.org\/10.1093\/sleep\/20.12.1093","journal-title":"Sleep"},{"key":"1412_CR6","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1124\/mol.59.6.1533","volume":"59","author":"AM Carruthers","year":"2001","unstructured":"Carruthers AM, Sellers LA, Jenkins DW et al (2001) Adenosine A1 receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons. Mol Pharmacol 59:1533\u20131541. https:\/\/doi.org\/10.1124\/mol.59.6.1533","journal-title":"Mol Pharmacol"},{"key":"1412_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","volume":"93","author":"SY Chou","year":"2005","unstructured":"Chou SY, Lee YC, Chen HM et al (2005) CGS21680 attenuates symptoms of Huntington\u2019s disease in a transgenic mouse model. J Neurochem 93:310\u2013320. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03029.x","journal-title":"J Neurochem"},{"key":"1412_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/1735-5362.189301","volume":"11","author":"MN Dastjerdi","year":"2016","unstructured":"Dastjerdi MN, Rarani MZ, Valiani A, Mahmoudieh M (2016) The effect of adenosine A1 receptor agonist and antagonist on p53 and caspase 3, 8, and 9 expression and apoptosis rate in MCF-7 breast cancer cell line. Res Pharm Sci 11:303\u2013310. https:\/\/doi.org\/10.4103\/1735-5362.189301","journal-title":"Res Pharm Sci"},{"key":"1412_CR9","doi-asserted-by":"publisher","first-page":"H157","DOI":"10.1152\/ajpheart.1989.257.1.h157","volume":"257","author":"FM Faraci","year":"1989","unstructured":"Faraci FM, Kadel KA, Heistad DD (1989) Vascular responses of dura mater. Am J Physiol - Hear Circ Physiol 257:H157-61. https:\/\/doi.org\/10.1152\/ajpheart.1989.257.1.h157","journal-title":"Am J Physiol - Hear Circ Physiol"},{"key":"1412_CR10","doi-asserted-by":"publisher","first-page":"7156","DOI":"10.1021\/ACS.JMEDCHEM.1C00261","volume":"64","author":"G Faudone","year":"2021","unstructured":"Faudone G, Arifi S, Merk D (2021) The Medicinal Chemistry of Caffeine. J Med Chem 64:7156\u20137178. https:\/\/doi.org\/10.1021\/ACS.JMEDCHEM.1C00261","journal-title":"J Med Chem"},{"key":"1412_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/brainsci7030030","volume":"7","author":"NT Fried","year":"2017","unstructured":"Fried NT, Elliott MB, Oshinsky ML (2017) The Role of Adenosine Signaling in Headache: A Review. Brain Sci 7:30. https:\/\/doi.org\/10.3390\/brainsci7030030","journal-title":"Brain Sci"},{"key":"1412_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1046\/j.1468-2982.2003.00511.x","volume":"23","author":"NJ Giffin","year":"2003","unstructured":"Giffin NJ, Kowacs F, Libri V et al (2003) Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects. Cephalalgia 23:287\u2013292. https:\/\/doi.org\/10.1046\/j.1468-2982.2003.00511.x","journal-title":"Cephalalgia"},{"key":"1412_CR13","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1093\/brain\/awf141","volume":"125","author":"PJ Goadsby","year":"2002","unstructured":"Goadsby PJ, Hoskin KL, Storer RJ et al (2002) Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain 125:1392\u20131401. https:\/\/doi.org\/10.1093\/brain\/awf141","journal-title":"Brain"},{"key":"1412_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/glia.22599","volume":"62","author":"E Gonz\u00e1lez-Fern\u00e1ndez","year":"2014","unstructured":"Gonz\u00e1lez-Fern\u00e1ndez E, S\u00e1nchez-G\u00f3mez MV, P\u00e9rez-Samart\u00edn A et al (2014) A3 Adenosine receptors mediate oligodendrocyte death and ischemic damage to optic nerve. Glia 62:199\u2013216. https:\/\/doi.org\/10.1002\/glia.22599","journal-title":"Glia"},{"key":"1412_CR15","doi-asserted-by":"publisher","unstructured":"Haanes KA, Edvinsson L (2014) Expression and characterization of purinergic receptors in rat middle meningeal artery-potential role in migraine.\u00a0PLoS One\u00a09(9):e108782\u2013e108782. https:\/\/doi.org\/10.1371\/journal.pone.0108782","DOI":"10.1371\/journal.pone.0108782"},{"key":"1412_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-018-0867-x","volume":"19","author":"KA Haanes","year":"2018","unstructured":"Haanes KA, Labastida-Ram\u00edrez A, Chan KY et al (2018) Characterization of the trigeminovascular actions of several adenosine A2A receptor antagonists in an in vivo rat model of migraine. J Headache Pain 19:1\u201310. https:\/\/doi.org\/10.1186\/s10194-018-0867-x","journal-title":"J Headache Pain"},{"key":"1412_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.10.1.58","author":"JE Hardebo","year":"1979","unstructured":"Hardebo JE, Edvinsson L (1979) Adenine compounds: Cerebrovascular effects In Vitro with reference to their possible involvement in migraine. Stroke. https:\/\/doi.org\/10.1161\/01.STR.10.1.58","journal-title":"Stroke"},{"key":"1412_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF00944394","volume":"144","author":"L Heseltine","year":"1995","unstructured":"Heseltine L, Webster JM, Taylor R (1995) Adenosine effects upon insulin action on lipolysis and glucose transport in human adipocytes. Mol Cell Biochem 144:147\u2013151. https:\/\/doi.org\/10.1007\/BF00944394","journal-title":"Mol Cell Biochem"},{"key":"1412_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1046\/j.1468-2982.2002.00345.x","volume":"22","author":"AC Honey","year":"2002","unstructured":"Honey AC, Bland-Ward PA, Connor HE et al (2002) Study of an adenosine A1 receptor agonist on trigeminally evoked dural blood vessel dilation in the anaesthetized rat. Cephalalgia 22:260\u2013264. https:\/\/doi.org\/10.1046\/j.1468-2982.2002.00345.x","journal-title":"Cephalalgia"},{"key":"1412_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nrd1983","volume":"5","author":"KA Jacobson","year":"2006","unstructured":"Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5:247\u2013264. https:\/\/doi.org\/10.1038\/nrd1983","journal-title":"Nat Rev Drug Discov"},{"key":"1412_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2019.00124","volume":"13","author":"KA Jacobson","year":"2019","unstructured":"Jacobson KA, Tosh DK, Jain S, Gao ZG (2019) Historical and current adenosine receptor agonists in preclinical and clinical development. Front Cell Neurosci 13:1\u201317. https:\/\/doi.org\/10.3389\/fncel.2019.00124","journal-title":"Front Cell Neurosci"},{"key":"1412_CR22","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/sj.bjp.0704357","volume":"134","author":"DW Jenkins","year":"2001","unstructured":"Jenkins DW, Feniuk W, Humphrey PPA (2001) Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones. Br J Pharmacol 134:1296\u20131302. https:\/\/doi.org\/10.1038\/sj.bjp.0704357","journal-title":"Br J Pharmacol"},{"key":"1412_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/S11302-020-09694-2","volume":"16","author":"JF Chen","year":"2020","unstructured":"Chen JF, Cunha RA (2020) The belated US FDA approval of the adenosine A 2A receptor antagonist istradefylline for treatment of Parkinson\u2019s disease. Purinergic Signal 16:167\u2013174. https:\/\/doi.org\/10.1007\/S11302-020-09694-2","journal-title":"Purinergic Signal"},{"key":"1412_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/BRAIN\/AWU330","volume":"138","author":"JW Little","year":"2015","unstructured":"Little JW, Ford A, Symons-Liguori AM et al (2015) Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. Brain 138:28\u201335. https:\/\/doi.org\/10.1093\/BRAIN\/AWU330","journal-title":"Brain"},{"key":"1412_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/heart.87.2.115","volume":"87","author":"AD Kelion","year":"2002","unstructured":"Kelion AD, Webb TP, Gardner MA et al (2002) Does a selective adenosine A1 receptor agonist protect against exercise induced ischaemia in patients with coronary artery disease? Heart 87:115\u2013120. https:\/\/doi.org\/10.1136\/heart.87.2.115","journal-title":"Heart"},{"key":"1412_CR26","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1990.259.3.H820","volume-title":"Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes","author":"GE Kirsch","year":"1990","unstructured":"Kirsch GE, Codina J, Birnbaumer L, Brown AM (1990) Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes"},{"key":"1412_CR27","volume-title":"Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase (vasodilation\/glibenclamide\/hypoxia\/P1 receptors)","author":"T Kleppisch","year":"1995","unstructured":"Kleppisch T, Nelson MT (1995) Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase (vasodilation\/glibenclamide\/hypoxia\/P1 receptors)"},{"key":"1412_CR28","doi-asserted-by":"publisher","first-page":"e00037","DOI":"10.1002\/phy2.37","volume":"1","author":"S Kunduri","year":"2013","unstructured":"Kunduri S, Dick G, Nayeem M, Mustafa S (2013) Adenosine A(1) receptor signaling inhibits BK channels through a PKC\u03b1-dependent mechanism in mouse aortic smooth muscle. Physiol Rep 1:e00037. https:\/\/doi.org\/10.1002\/phy2.37","journal-title":"Physiol Rep"},{"key":"1412_CR29","doi-asserted-by":"publisher","first-page":"67060","DOI":"10.1371\/journal.pone.0067060","volume":"8","author":"M Li","year":"2013","unstructured":"Li M, Kang R, Shi J et al (2013) Anticonvulsant Activity of B2, an Adenosine Analog, on Chemical Convulsant-Induced Seizures. PLoS ONE 8:67060. https:\/\/doi.org\/10.1371\/journal.pone.0067060","journal-title":"PLoS ONE"},{"key":"1412_CR30","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/onc.2009.409","volume":"29","author":"Z Lin","year":"2010","unstructured":"Lin Z, Yin P, Reierstad S et al (2010) Adenosine A1 receptor, a target and regulator of estrogen receptor\u03b1 action, mediates the proliferative effects of estradiol in breast cancer. Oncogene 29:1114\u20131122. https:\/\/doi.org\/10.1038\/onc.2009.409","journal-title":"Oncogene"},{"key":"1412_CR31","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/jcbfm.2014.146","volume":"34","author":"BE Lindquist","year":"2014","unstructured":"Lindquist BE, Shuttleworth CW (2014) Spreading depolarization-induced adenosine accumulation reflects metabolic status in vitro and in vivo. J Cereb Blood Flow Metab 34:1779\u20131790. https:\/\/doi.org\/10.1038\/jcbfm.2014.146","journal-title":"J Cereb Blood Flow Metab"},{"key":"1412_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3892\/br.2016.591","volume":"4","author":"W Lu","year":"2016","unstructured":"Lu W, Li B, Chen J et al (2016) Expression of calcitonin gene-related peptide, adenosine A2a receptor and adenosine A1 receptor in experiment rat migraine models. Biomed Reports 4:379\u2013383. https:\/\/doi.org\/10.3892\/br.2016.591","journal-title":"Biomed Reports"},{"key":"1412_CR33","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1096\/fj.14-265066","volume":"29","author":"A Mediero","year":"2015","unstructured":"Mediero A, Wilder T, Perez-Aso M, Cronstein BN (2015) Direct or indirect stimulation of adenosine A2Areceptors enhances bone regeneration as well as bone morphogenetic protein-2. FASEB J 29:1577\u20131590. https:\/\/doi.org\/10.1096\/fj.14-265066","journal-title":"FASEB J"},{"key":"1412_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/NU12082259","volume":"12","author":"M Nowaczewska","year":"2020","unstructured":"Nowaczewska M, Wici\u0144ski M, Ka\u017amierczak W (2020) The Ambiguous Role of Caffeine in Migraine Headache: From Trigger to Treatment. Nutrients 12:1\u201316. https:\/\/doi.org\/10.3390\/NU12082259","journal-title":"Nutrients"},{"key":"1412_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF00180011","volume":"350","author":"M Oca\u00f1a","year":"1994","unstructured":"Oca\u00f1a M, Baeyens JM (1994) Role of ATP-sensitive K+ channels in antinociception induced by R-PIA, an adenosine A1 receptor agonist. Naunyn Schmiedebergs Arch Pharmacol 350:57\u201362. https:\/\/doi.org\/10.1007\/BF00180011","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1412_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-8-31","volume":"8","author":"I Paterniti","year":"2011","unstructured":"Paterniti I, Melani A, Cipriani S et al (2011) Selective adenosine A2Areceptor agonists and antagonists protect against spinal cord injury through peripheral and central effects. J Neuroinflammation 8:1\u201314. https:\/\/doi.org\/10.1186\/1742-2094-8-31","journal-title":"J Neuroinflammation"},{"key":"1412_CR37","doi-asserted-by":"publisher","first-page":"7590","DOI":"10.4049\/jimmunol.180.11.7590","volume":"180","author":"D Ragozzino","year":"2021","unstructured":"Ragozzino D, Limatola C, Sobrero F et al (2021) Hippocampal Neurons Neuroprotection and Neuromodulation in CL1-Mediated 3 Required for CX Activity of Adenosine Receptors Type 1 Is. J Immunol Ref 180:7590\u20137596. https:\/\/doi.org\/10.4049\/jimmunol.180.11.7590","journal-title":"J Immunol Ref"},{"key":"1412_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jsps.2012.05.011","volume":"21","author":"S Sachdeva","year":"2013","unstructured":"Sachdeva S, Gupta M (2013) Adenosine and its receptors as therapeutic targets: An overview. Saudi Pharm J 21:245\u2013253. https:\/\/doi.org\/10.1016\/j.jsps.2012.05.011","journal-title":"Saudi Pharm J"},{"key":"1412_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2015.10.031","volume":"338","author":"J Sawynok","year":"2016","unstructured":"Sawynok J (2016) Adenosine receptor targets for pain. Neuroscience 338:1\u201318","journal-title":"Neuroscience"},{"key":"1412_CR40","doi-asserted-by":"publisher","first-page":"10941","DOI":"10.26355\/eurrev_202011_23577","volume":"24","author":"WT Shen","year":"2020","unstructured":"Shen WT, Huang YJ, Zhang Q et al (2020) SCH58261, the antagonist of adenosine A2A receptor, alleviates cadmium-induced preeclampsia via sirtiun-1\/hypoxia-inducible factor-1a pathway in rats. Eur Rev Med Pharmacol Sci 24:10941\u201310953. https:\/\/doi.org\/10.26355\/eurrev_202011_23577","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1412_CR41","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/bja\/aem075","volume":"98","author":"RJ Sneyd","year":"2007","unstructured":"Sneyd RJ, Langton JA, Allan LG et al (2007) Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. Br J Anaesth 98:672\u2013676. https:\/\/doi.org\/10.1093\/bja\/aem075","journal-title":"Br J Anaesth"},{"key":"1412_CR42","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00210-018-1551-z","volume":"391","author":"A Szopa","year":"2018","unstructured":"Szopa A, Poleszak E, Bogatko K et al (2018) DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests. Naunyn Schmiedebergs Arch Pharmacol 391:1361. https:\/\/doi.org\/10.1007\/s00210-018-1551-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1412_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0163-7258(01)00152-8","volume":"91","author":"R Tabrizchi","year":"2001","unstructured":"Tabrizchi R, Bedi S (2001) Pharmacology of adenosine receptors in the vasculature. Pharmacol Ther 91:133\u2013147","journal-title":"Pharmacol Ther"},{"key":"1412_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0008-6363(01)00435-7","volume":"53","author":"LKK Teoh","year":"2002","unstructured":"Teoh LKK, Grant R, Hulf JA et al (2002) The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. Cardiovasc Res 53:175\u2013180. https:\/\/doi.org\/10.1016\/S0008-6363(01)00435-7","journal-title":"Cardiovasc Res"},{"key":"1412_CR45","doi-asserted-by":"publisher","unstructured":"Thuraiaiyah J, Kokoti L, Al-Karagholi MA, Ashina M (2022) Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies. Cephalalgia. https:\/\/doi.org\/10.1177\/03331024221077665.","DOI":"10.1177\/03331024221077665"},{"key":"1412_CR46","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/01.RES.70.6.1313","volume":"70","author":"EP Wei","year":"1992","unstructured":"Wei EP, Moskowitz MA, Boccalini P, Kontos HA (1992) Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ Res 70:1313\u20131319. https:\/\/doi.org\/10.1161\/01.RES.70.6.1313","journal-title":"Circ Res"},{"key":"1412_CR47","doi-asserted-by":"publisher","first-page":"114340","DOI":"10.1016\/j.bcp.2020.114340","volume":"183","author":"Y Yang","year":"2021","unstructured":"Yang Y, Zhang H, Lu Q et al (2021) Suppression of adenosine A2a receptors alleviates bladder overactivity and hyperalgesia in cyclophosphamide-induced cystitis by inhibiting TRPV1. Biochem Pharmacol 183:114340. https:\/\/doi.org\/10.1016\/j.bcp.2020.114340","journal-title":"Biochem Pharmacol"},{"key":"1412_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11302-016-9521-8","volume":"12","author":"GG Yegutkin","year":"2016","unstructured":"Yegutkin GG, Guerrero-Toro C, Kilinc E et al (2016) Nucleotide homeostasis and purinergic nociceptive signaling in rat meninges in migraine-like conditions. Purinergic Signal 12:561\u2013574. https:\/\/doi.org\/10.1007\/s11302-016-9521-8","journal-title":"Purinergic Signal"},{"key":"1412_CR49","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.peptides.2008.09.003","volume":"29","author":"K Yuan","year":"2008","unstructured":"Yuan K, Bai GY, Park WH et al (2008) Stimulation of ANP secretion by 2-Cl-IB-MECA through A3 receptor and CaMKII. Peptides 29:2216\u20132224. https:\/\/doi.org\/10.1016\/j.peptides.2008.09.003","journal-title":"Peptides"},{"key":"1412_CR50","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1159\/000481557","volume":"43","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Tong L, Chu X et al (2017) The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK\/JNK Pathway in Renal Cell Carcinoma. Cell Physiol Biochem 43:733\u2013742. https:\/\/doi.org\/10.1159\/000481557","journal-title":"Cell Physiol Biochem"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01412-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-022-01412-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01412-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:11:21Z","timestamp":1649142681000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-022-01412-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1186\/s10194-022-01412-0","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JT, LK and MMK report no conflict of interest. MA has received consulting fees and honoraria for lectures\/presentations from AbbVie, Allergan, Amgen, Eli Lily, Lundbeck, Novartis and Teva. MA has also received personal payments for participating on data Safety Monitoring Board or Advisory Board for AbbVie, Amgen, Eli Lily, Lundbeck and Novartis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}